Karl‐Ludwig Laugwitz

Author

Also Known As

Christian Butter, Heribert Schunkert, K L Laugwitz, K Laugwitz, K. -L. Laugwitz, K. L. Laugwitz, K. Tiroch, K.- L. Laugwitz, K.-L Laugwitz, K.-L. Laugwitz

442

Publications

18.2K

Citations

H-Index

133

Concepts

All Affiliations

Klinikum rechts der Isar German Centre for Cardiovascular Research Deutsches Herzzentrum München Technical University of Munich Ludwig-Maximilians-Universität München

About

Karl‐Ludwig Laugwitz is an author at Klinikum rechts der Isar specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	85	7.8K
2	Engineering	4	4	75
3	Health Sciences	4	4	113
4	Natural Sciences	3	3	155
5	Education	1	1	31

Karl‐Ludwig Laugwitz

208

Publications

16K

Citations

H-Index

Page 1

	Year	Citations
Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages Karl‐Ludwig Laugwitz, Alessandra Moretti, Jason T. Lam, Nature Postnatal Isl1+ CardioblastsCardiomyopathyCardiac MuscleCardiac ReprogrammingDevelopmental Biology	2005	1.3K
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome Alessandra Moretti, Milena Bellin, Andrea Welling, New England Journal of Medicine	2010	1.2K
Multipotent Embryonic Isl1+ Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell Diversification Alessandra Moretti, Leslie Caron, Atsushi Nakano, Cell Cardiac MuscleDevelopmental BiologyAngiogenesisCell SpecializationMedicine	2006	1K
Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Robert A. Byrne, Franz–Josef Neumann, Julinda Mehilli, The Lancet Endovascular TechniqueCardiovascular DiseasePaclitaxel-eluting BalloonsPaclitaxel-eluting StentsVascular Surgery	2012	441
Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography Salvatore Cassese, Robert A. Byrne, Tomohisa Tada, Heart	2013	435
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation K. Anette Fiedler, Julinda Mehilli, Stefanie Schüpke, Journal of the American College of Cardiology Drug-eluting Stent ImplantationThrombosisEndovascular TechniqueCardiovascular DiseaseTriple Therapy	2015	431
Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents Tomohisa Tada, Robert A. Byrne, Iva Šimunović, JACC: Cardiovascular Interventions ThrombosisStent ThrombosisVascular DiseaseFirst-generation Drug-eluting StentsVenous Thrombosis	2013	331
Abciximab and Heparin versus Bivalirudin for Non–ST-Elevation Myocardial Infarction Adnan Kastrati, Franz‐Josef Neumann, S. Schulz, New England Journal of Medicine	2011	311
The Renewal and Differentiation of Isl1+ Cardiovascular Progenitors Are Controlled by a Wnt/β-Catenin Pathway Yibing Qyang, Silvia Martı́n-Puig, Murali Chiravuri, Cell stem cell Cardiac MuscleDevelopmental BiologyCardiac ReprogrammingCardiovascular DiseaseSignaling Pathway	2007	310
Activated Platelets Induce Monocyte Chemotactic Protein-1 Secretion and Surface Expression of Intercellular Adhesion Molecule-1 on Endothelial Cells Meinrad Gawaz, Franz‐Josef Neumann, Timm Dickfeld, Circulation	1998	299

Page 1